LeMaitre Vascular Inc (LMAT)
78.88
+0.11
(+0.14%)
USD |
NASDAQ |
May 31, 16:00
78.89
+0.01
(+0.01%)
Pre-Market: 20:00
LeMaitre Vascular Gross Profit (Quarterly): 36.66M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 36.66M |
December 31, 2023 | 33.26M |
September 30, 2023 | 30.82M |
June 30, 2023 | 32.09M |
March 31, 2023 | 30.88M |
December 31, 2022 | 26.05M |
September 30, 2022 | 25.07M |
June 30, 2022 | 27.81M |
March 31, 2022 | 25.96M |
December 31, 2021 | 25.96M |
September 30, 2021 | 24.87M |
June 30, 2021 | 26.76M |
March 31, 2021 | 23.80M |
December 31, 2020 | 24.40M |
September 30, 2020 | 22.70M |
June 30, 2020 | 17.03M |
March 31, 2020 | 20.48M |
December 31, 2019 | 19.91M |
September 30, 2019 | 20.17M |
June 30, 2019 | 20.32M |
March 31, 2019 | 19.46M |
December 31, 2018 | 19.22M |
September 30, 2018 | 17.26M |
June 30, 2018 | 18.99M |
March 31, 2018 | 18.47M |
Date | Value |
---|---|
December 31, 2017 | 18.25M |
September 30, 2017 | 17.58M |
June 30, 2017 | 17.52M |
March 31, 2017 | 17.35M |
December 31, 2016 | 16.19M |
September 30, 2016 | 17.02M |
June 30, 2016 | 15.37M |
March 31, 2016 | 14.36M |
December 31, 2015 | 14.40M |
September 30, 2015 | 13.52M |
June 30, 2015 | 13.13M |
March 31, 2015 | 13.12M |
December 31, 2014 | 12.83M |
September 30, 2014 | 12.00M |
June 30, 2014 | 12.38M |
March 31, 2014 | 11.22M |
December 31, 2013 | 11.96M |
September 30, 2013 | 10.72M |
June 30, 2013 | 11.24M |
March 31, 2013 | 11.21M |
December 31, 2012 | 10.44M |
September 30, 2012 | 10.02M |
June 30, 2012 | 10.54M |
March 31, 2012 | 9.87M |
December 31, 2011 | 9.523M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
17.03M
Minimum
Jun 2020
36.66M
Maximum
Mar 2024
25.75M
Average
25.51M
Median
Gross Profit (Quarterly) Benchmarks
Baxter International Inc | 1.387B |
AtriCure Inc | 81.27M |
Becton Dickinson & Co | 2.304B |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | 17.30M |